We further used our clinical pancreatic cancer specimens to analyzed the LDHA levels in pancreatic cancer patients receiving treatment with gemcitabine and observed that patients with better overall-survival (OS) and recurrence-free survival (RFS) showed lower level of LDHA expression (Fig. 1F). Here, LDHA is linked to pancreatic neoplasm.